Drugs, Vol. 76, Issue 5 - New Issue Alert

If this email is not displayed correctly, please click here to read this table of contents online.

New Issue Alert 03/29/2016 Dear Alexandros Sfakianakis, We are pleased to deliver your requested table of contents alert for Drugs. Volume 76 Number 5 is now available online. In this issue Current Opinion Two-Drug Treatment Approaches in HIV: Finally Getting Somewhere? Sean G. Kelly, Amesika N. Nyaku & Babafemi O. Taiwo » Abstract   » Full text HTML   » Full text PDF Leading Article Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection Denise C. Hsu & Irini Sereti » Abstract   » Full text HTML   » Full text PDF Therapy in Practice The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions Paolo Curatolo, Marit Bjørnvold, Patricia E. Dill, José Carlos Ferreira, Martha Feucht, Christoph Hertzberg, Anna Jansen, Sergiusz Jóźwiak, J. Christopher Kingswood, Katarzyna Kotulska, Alfons Macaya, Romina Moavero, Rima Nabbout & Bernard A. Zonnenberg » Abstract   » Full text HTML   » Full text PDF Review Article Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent George G. Zhanel, Doris Cheung, Heather Adam, Sheryl Zelenitsky, Alyssa Golden, Frank Schweizer, Bala Gorityala, Philippe R. S. Lagacé-Wiens, Andrew Walkty, Alfred S. Gin, Daryl J. Hoban & James A. Karlowsky » Abstract   » Full text HTML   » Full text PDF Review Article Antipsychotic Management of Schizoaffective Disorder: A Review Jean-Pierre Lindenmayer & Amandeep Kaur » Abstract   » Full text HTML   » Full text PDF Adis Drug Evaluation Cobimetinib Plus Vemurafenib: A Review in BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Gillian M. Keating » Abstract   » Full text HTML   » Full text PDF AdisInsight Report Elbasvir/Grazoprevir: First Global Approval Gillian M. Keating » Abstract   » Full text HTML   » Full text PDF Letter to the Editor Comment on: "Therapies to Preserve β-Cell Function in Type 1 Diabetes" Devi Dayal » Abstract   » Full text HTML   » Full text PDF Letter to the Editor Author's Reply to Dayal: "Therapies to Preserve β-Cell Function in Type 1 Diabetes" Johnny Ludvigsson » Abstract   » Full text HTML   » Full text PDF Do you want to publish your article in this journal? Please visit the homepage of Drugs for full details on: aims and scope editorial policy article submission Impact Factor: 4.343 (2014) Journal Citation Reports®, Thomson Reuters Read open access articles Click here to view all open access articles published in this journal. Interested in publishing your article open access? When you opt for Open Choice, you retain full copyright and your article is permanently freely available. Sign up for SpringerAlerts! Register for Springer's email services providing you with info on the latest books in your field. » Click here This email has been sent to alsfakia.journals2@blogger.com You are receiving this email because you have opted to receive information from SpringerAlerts as a registered user of our Table of Content Alert for journals. To ensure the delivery to your inbox, please add the sender address springer@alerts.springer.com to your allow list. To modify your subscription (including change of email address etc.), please go to http://ift.tt/Lqiruf and log in with your email address and password. To unsubscribe from this specific table of contents alert, please click here. To unsubscribe from ALL table of contents alerts, please click here. For all enquiries, problems or suggestions regarding this service, please contact onlineservice@springer.com. Springer respects your privacy and does not disclose, sell or rent your personal information to any nonaffiliated third parties without your consent. Please visit the Springer Privacy Statement. Springer-Verlag GmbH Heidelberg, Tiergartenstrasse 17, 69121 Heidelberg, Germany, phone: +49 6221 487 0, fax: +49 6221 487 8366 © Springer 2016, springer.com

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1oiuRb4
via IFTTT